Rezolute, Inc. (MUN:6HV1) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Announced: about US$100M · US$3.87 a share · Morgan Stanley +6 Dealers: Morgan Stanley (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), H.C. Wainwright & Co., Jones, Maxim Group LLC, Lake Street Capital Markets, LLC Buyers: Frazier Life Sciences Use of proceeds: Ersodetug commercialization preparation, working capital and general corporate purposes | Nov 13, 2026 |
| Public offering of common stock and pre-funded warrants Closed: US$96.9M raised · US$3.25 a share · Guggenheim Securities +6 Dealers: Guggenheim Securities (lead), BTIG (co-lead), H.C. Wainwright & Co. (co-lead), Jones (co-lead), Craig-Hallum, Maxim Group LLC, WG Partners LLP Buyers: Federated Hermes Kaufmann Funds; Blackstone Multi-Asset Investing; Great Point Partners, LLC; Marshall Wace; Woodline Partners LP; Nantahala Capital; Squadron Capital Management Use of proceeds: Research and development, general corporate expenses and working capital needs | Apr 25, 2025 |
| Private placement of shares of common stock Announced: up to US$4.2M | Apr 25, 2025 |